Biocons Generic Formulations Facility in Bengaluru completes U.S. FDA Inspection with No 483 observations
12-Nov-2018
Biocons Generic Formulations Facility in Bengaluru completes U.S. FDA Inspection with No 483 observations
Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds